Regulated C-myc gene expression is an important determinant of cell
proliferation and differentiation and averts neoplastic cell behavior.
Regulation usually occurs at the mRNA level, depends on the marked
instability of the mRNA for its rapidity and is frequently
post-transcriptional. Preliminary studies show that C2 murine myoblasts
express abundant c-myc mRNA and that the turnover of this mRNA is rapid and
depends on translation of C-terminal protein-coding sequences.
Differentiation of C2 cells is accompanied by a fall in c-myc mRNA levels,
which is due to accelerated turnover that also depends on translation of
C-terminal protein-coding sequences. The goal of this proposal is to
understand these post-transcriptional mechanisms regulating c-myc
expression. (I) Delineation of the structural determinant of translation-
dependent c-myc mRNA instability will be accomplished by testing myc
deletion and fusion mRNAs for induction by cycloheximide, which has been
shown to be due to mRNA stabilization by drug inhibition of translation and
is indicative of an unstable myc mRNA. Study of point and frame-shift
mutants will indicate if the nucleotide sequence or the encoded amino acid
sequence of this element is the instability determinant. A similar
approach will be used to delineate the structural element targeting c-myc
mRNA for regulation during C2 differentiation. This task may be simplified
by selecting only the most informative myc genes from the cycloheximide
studies for testing in the cumbersome C2 differentiation assay, since
preliminary studies indicate that the determinants of regulation and
instability may be the same. (II) Identification of these c-myc mRNA
structural determinants will be followed by characterization of their
significance. The current confusion resulting from the multiplicity of
putative destabilizing elements identified in c-myc mRNA to date will be
resolved by determining which candidate element actually influences the
steady-state level of c-myc mRNA by specifying its rate of turnover. The
prevalence of translation-dependent mechanisms for c-myc mRNA instability
and regulation during differentiation will be determined by examining their
usage in other cell types. If mRNAs other than c-myc are regulated by the
same mechanism during differentiation, they may share the myc mRNA
regulatory motif and be identifiable on this basis using appropriate search
or cloning strategies. (III) Knowledge gained about the cis-acting motifs
regulating c-myc mRNA levels will be used to characterize the transacting
factors involved. One approach will be to establish an in vitro system of
c-myc mRNA degradation that faithfully recapitulates in vivo events and can
be used to characterize and purify these factors. If a nucleotide sequence
forms the regulatory motif, identification of factors that bind this
sequence offers another approach. These studies promise to reveal factors
involved in the regulation of cellular mRNA turnover and to disclose the
molecular basis of post-transcriptional c-myc mRNA regulation, a key
element of the cell's normal response to growth and differentiation
stimuli.
No Sub Projects information available for 5R01GM047147-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM047147-03
Patents
No Patents information available for 5R01GM047147-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM047147-03
Clinical Studies
No Clinical Studies information available for 5R01GM047147-03
News and More
Related News Releases
No news release information available for 5R01GM047147-03
History
No Historical information available for 5R01GM047147-03
Similar Projects
No Similar Projects information available for 5R01GM047147-03